Please read and agree to the terms and conditions of this site.
@tech.eu 1 year ago
Want to live longer? This Berlin startup aims to bring you back from the dead
@techcrunch.com 1 year ago
Nanopath is looking to drastically change medical diagnostics
@techcrunch.com 2 years ago
Sirona Medical Acquires Nines AI’s algorithms to rebuild radiology’s IT from the ground up
@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@techcrunch.com 2 years ago
Kiwi Bio aims to free irritable bowel syndrome sufferers from restrictive diets
@techcrunch.com 2 years ago
GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor
@techcrunch.com 2 years ago
Alpha Medical closes $24M Series B round to expand women’s telehealth – without the video calls
@techcrunch.com 2 years ago
How Colossal sold investors on a quest to resurrect a woolly mammoth
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 2 years ago
Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy”
@techcrunch.com 3 years ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@tech.eu 3 years ago
Swiss medtech startup Bloom Diagnostics launches new testing system after €10 million Series B
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu 3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@tech.eu 3 years ago
French medtech company UroMems raises €16 million Series B
@xconomy.com 3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com 4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com 4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com 4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@engadget.com 4 years ago
Chicago biotech company 3D prints a mini human heart
@xconomy.com 4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com 4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@techcrunch.com 4 years ago
How to watch Elon Musk’s Neuralink brain control interface startup presentation live
@techcrunch.com 4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@techcrunch.com 4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com 4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com 4 years ago
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More
@xconomy.com 5 years ago
Corza Health Emerges Led by Former NuVasive, GreatCall Executives
@techcrunch.com 5 years ago
Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests
@xconomy.com 5 years ago
Connect Honors 7 New Products as ‘Most Innovative’ at Annual Awards
@xconomy.com 5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com 5 years ago
NorthStar Names Merrick CEO, Appoints Hendricks as Board Chair
@xconomy.com 5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence
@xconomy.com 5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com 5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round
@xconomy.com 5 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
@techcrunch.com 6 years ago
With $250 million, Peter Diamandis’ new startup is all about taking stem cells from placentas
@thenextweb.com 8 years ago
You could soon be taking a robot pill that delivers drugs with sugar needles